LIFECORE BIOMEDICAL, INC. Increase (Decrease) in Contract with Customer, Liability
LIFECORE BIOMEDICAL, INC. (LFCR) reported Increase (Decrease) in Contract with Customer, Liability of $3.14 million for the 12-month period ending 2023-05-28, per its 10-K filed 2024-03-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2024-03-20
- LIFECORE BIOMEDICAL, INC. increase (decrease) in contract with customer, liability for the quarter ending 2023-05-28 was $1.34M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in contract with customer, liability for the quarter ending 2023-02-26 was $1.98M, a 213.29% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in contract with customer, liability for the quarter ending 2022-11-27 was -$72.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in contract with customer, liability for the quarter ending 2022-08-28 was -$116.00K, a 234.88% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in contract with customer, liability for fiscal 2023 was $3.14M.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in contract with customer, liability for fiscal 2022 was -$18.00K, a 104.21% decline from fiscal 2021.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in contract with customer, liability for fiscal 2021 was $428.00K.
- LIFECORE BIOMEDICAL, INC. increase (decrease) in contract with customer, liability for fiscal 2020 was -$147.00K.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 9 month as first filed | Increase (Decrease) in Contract with Customer, Liability 12 month | Increase (Decrease) in Contract with Customer, Liability 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-05-28 | $1.34M derived: 10-K 12 month − 10-K 9 month · filed 2024-03-20 | $3.32M derived: sum of 2 quarters · filed 2024-03-20 | $3.25M derived: sum of 3 quarters · filed 2024-03-20 | $3.14M 10-K · filed 2024-03-20 | ||
| 2023-02-26 | $1.98M derived: 10-K 9 month − 10-K 6 month · filed 2024-03-20 | $1.91M derived: sum of 2 quarters · filed 2024-03-20 | $1.79M 10-K · filed 2024-03-20 | $1.11M derived: sum of 4 quarters · filed 2024-03-20 | ||
| 2022-11-27 | -$72.00K derived: 10-K 6 month − 10-K 3 month · filed 2024-03-20 | -$188.00K 10-K · filed 2024-03-20 | -$868.00K derived: sum of 3 quarters · filed 2024-03-20 | -$236.00K derived: sum of 4 quarters · filed 2024-03-20 | ||
| 2022-08-28 | -$116.00K 10-K · filed 2024-03-20 | -$796.00K derived: sum of 2 quarters · filed 2024-03-20 | -$164.00K derived: sum of 3 quarters · filed 2024-03-20 | -$220.00K derived: sum of 4 quarters · filed 2024-03-20 | ||
| 2022-05-29 | -$680.00K derived: 10-K 12 month − 10-K 9 month · filed 2024-03-20 | -$48.00K derived: sum of 2 quarters · filed 2024-03-20 | -$104.00K derived: sum of 3 quarters · filed 2024-03-20 | -$18.00K 10-K · filed 2024-03-20 | ||
| 2022-02-27 | $632.00K derived: 10-K 9 month − 10-K 6 month · filed 2024-03-20 | $576.00K derived: sum of 2 quarters · filed 2024-03-20 | $662.00K 10-K · filed 2024-03-20 | $204.00K 10-Q · filed 2022-04-07 | $197.00K derived: sum of 4 quarters · filed 2024-03-20 | |
| 2021-11-28 | -$56.00K derived: 10-K 6 month − 10-K 3 month · filed 2024-03-20 | $30.00K 10-K · filed 2024-03-20 | -$435.00K derived: sum of 3 quarters · filed 2024-03-20 | $166.00K derived: sum of 4 quarters · filed 2024-03-20 | ||
| 2021-08-29 | $86.00K 10-K · filed 2024-03-20 | -$379.00K derived: sum of 2 quarters · filed 2024-03-20 | $222.00K derived: sum of 3 quarters · filed 2024-03-20 | $389.00K derived: sum of 4 quarters · filed 2024-03-20 | ||
| 2021-05-30 | -$465.00K derived: 10-K 12 month − 10-K 9 month · filed 2024-03-20 | $136.00K derived: sum of 2 quarters · filed 2024-03-20 | $303.00K derived: sum of 3 quarters · filed 2024-03-20 | $428.00K 10-K · filed 2024-03-20 | $778.00K 10-K · filed 2021-07-29 | |
| 2021-02-28 | $601.00K derived: 10-K 9 month − 10-Q 6 month · filed 2024-03-20 | $768.00K derived: sum of 2 quarters · filed 2024-03-20 | $893.00K 10-K · filed 2024-03-20 | $1.24M 10-Q · filed 2021-04-08 | $627.00K derived: sum of 4 quarters · filed 2024-03-20 | |
| 2020-11-29 | $167.00K derived: 10-Q 6 month − 10-K 3 month · filed 2022-01-07 | $292.00K 10-Q · filed 2022-01-07 | $26.00K derived: sum of 3 quarters · filed 2024-03-20 | $33.00K derived: sum of 4 quarters · filed 2024-03-20 | ||
| 2020-08-30 | $125.00K 10-K · filed 2024-03-20 | -$141.00K derived: sum of 2 quarters · filed 2024-03-20 | -$134.00K derived: sum of 3 quarters · filed 2024-03-20 | -$11.00K derived: sum of 4 quarters · filed 2024-03-20 | ||
| 2020-05-31 | -$266.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16 | -$259.00K derived: sum of 2 quarters · filed 2023-03-16 | -$136.00K derived: sum of 3 quarters · filed 2023-03-16 | -$147.00K 10-K/A · filed 2023-03-16 | ||
| 2020-02-23 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-08 | $130.00K derived: sum of 2 quarters · filed 2021-04-08 | $119.00K 10-Q · filed 2021-04-08 | -$668.00K derived: sum of 4 quarters · filed 2021-07-29 | ||
| 2019-11-24 | $123.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-07 | $112.00K 10-Q · filed 2021-01-07 | -$675.00K derived: sum of 3 quarters · filed 2021-07-29 | -$1.31M derived: sum of 4 quarters · filed 2021-07-29 | ||
| 2019-08-25 | -$11.00K 10-Q · filed 2020-10-07 | -$798.00K derived: sum of 2 quarters · filed 2021-07-29 | -$1.43M derived: sum of 3 quarters · filed 2021-07-29 | -$1.80M derived: sum of 4 quarters · filed 2021-07-29 | ||
| 2019-05-26 | -$787.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-29 | -$1.42M derived: sum of 2 quarters · filed 2021-07-29 | -$1.79M derived: sum of 3 quarters · filed 2021-07-29 | -$2.38M 10-K · filed 2021-07-29 | ||
| 2019-02-24 | -$632.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | -$1.00M derived: sum of 2 quarters · filed 2020-04-03 | -$1.59M 10-Q · filed 2020-04-03 | -$895.00K derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2018-11-25 | -$369.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-02 | -$958.00K 10-Q · filed 2020-01-02 | -$263.00K derived: sum of 3 quarters · filed 2020-08-14 | -$151.00K derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2018-08-26 | -$589.00K 10-Q · filed 2019-10-03 | $106.00K derived: sum of 2 quarters · filed 2020-08-14 | $218.00K derived: sum of 3 quarters · filed 2020-08-14 | |||
| 2018-05-27 | $695.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14 | $807.00K derived: sum of 2 quarters · filed 2020-08-14 | $2.17M 10-K · filed 2020-08-14 | |||
| 2018-02-25 | $112.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-04 | $1.48M 10-Q · filed 2019-04-04 | ||||
| 2017-11-26 | $1.36M 10-Q · filed 2019-01-07 | |||||
| 2017-05-28 | -$522.00K 10-K · filed 2019-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |